Insider Trading & Ownership - Phathom Pharmaceuticals Inc. (PHAT)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Phathom Pharmaceuticals Inc.
Goto Prev, 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2024-04-08
Sale		 2024-04-10
4:30 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 3,435 $11.1 $38,129 97,174
(Indirect
Direct)		 View
2024-03-22
Sale		 2024-03-26
4:05 pm		 Phathom Pharmaceuticals Inc. PHAT Curran Terrie
President and Chief Executive		 16,851 $9.11 $153,513 414,624
(Indirect
Direct)		 View
2024-01-24
Sale		 2024-01-25
06:13 am		 Phathom Pharmaceuticals Inc. PHAT TAKEDA PHARMACEUTICAL CO LTD
10% Owner		 3,703,703 $8.1 $29,999,994 3,755,583
(Direct)		 View
2024-01-19
Sale		 2024-01-22
8:22 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 6,307 $7.7533 $48,900 220,609
(Indirect
Direct)		 View
2023-11-20
Sale		 2023-11-21
4:40 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 2,127 $7.2415 $15,403 104,195
(Indirect
Direct)		 View
2023-11-06
Purchase		 2023-11-08
7:56 pm		 Phathom Pharmaceuticals Inc. PHAT Parikh Asit
Director		 7,500 $7.8107 $58,580 55,000
(Direct)		 View
2023-11-01
Sale		 2023-11-03
4:55 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 12,492 $8.8753 $110,871 106,322
(Indirect
Direct)		 View
2023-06-02
Sale		 2023-06-05
6:32 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 1,960 $11.41 $22,368 68,845
(Indirect
Direct)		 View
2023-05-22
Sale		 2023-05-23
12:15 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 2,110 $12.87 $27,165 70,805
(Indirect
Direct)		 View
2023-04-10
Purchase		 2023-04-11
4:05 pm		 Phathom Pharmaceuticals Inc. PHAT Parikh Asit
Director		 1,000 $7.55 $7,550 23,500
(Direct)		 View
2023-04-11
Purchase		 2023-04-11
4:05 pm		 Phathom Pharmaceuticals Inc. PHAT Nabulsi Azmi
Chief Operating Officer		 10,000 $8.26 $82,600 887,622
(Indirect
Direct)		 View
2023-04-06
Purchase		 2023-04-07
3:19 pm		 Phathom Pharmaceuticals Inc. PHAT Curran Terrie
President and Chief Executive		 12,919 $7.8199 $101,025 190,526
(Indirect
Direct)		 View
2023-04-06
Sale		 2023-04-07
3:18 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 3,439 $7.27 $25,002 72,915
(Indirect
Direct)		 View
2023-03-01
Sale		 2023-03-03
7:03 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 2,032 $8.5309 $17,335 76,354
(Indirect
Direct)		 View
2023-03-01
Sale		 2023-03-03
6:59 pm		 Phathom Pharmaceuticals Inc. PHAT Curran Terrie
President and Chief Executive		 1,436 $8.5411 $12,265 177,607
(Indirect
Direct)		 View
2023-02-13
Purchase		 2023-02-14
4:56 pm		 Phathom Pharmaceuticals Inc. PHAT Parikh Asit
Director		 5,000 $7.732 $38,660 22,500
(Direct)		 View
2023-01-20
Sale		 2023-01-20
7:39 pm		 Phathom Pharmaceuticals Inc. PHAT Curran Terrie
President and Chief Executive		 5,821 $8.1995 $47,729 341,543
(Indirect
Direct)		 View
2023-01-12
Purchase		 2023-01-12
4:32 pm		 Phathom Pharmaceuticals Inc. PHAT Parikh Asit
Director		 5,000 $7 $35,000 17,500
(Direct)		 View
2022-11-21
Sale		 2022-11-23
4:10 pm		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 2,159 $9.6 $20,726 43,680
(Indirect
Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-05-23
Option Award		 2024-05-24
7:18 pm		 N/A
2034-05-22		 Phathom Pharmaceuticals Inc. PHAT Stenhouse Mark
Director		 28,000 $0 37,000
(Direct)		 View
2024-05-23
Option Award		 2024-05-24
7:14 pm		 N/A
2034-05-22		 Phathom Pharmaceuticals Inc. PHAT Socks David A
Director		 28,000 $0 1,248,756
(Direct)		 View

Ownership		 2024-01-26
4:35 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Medicxi Ventures Management (Jersey) Ltd
Medicxi Growth I GP Ltd
Medicxi Growth I LP
Medicxi Growth Co-Invest I LP
Medicxi IV GP Ltd
Medicxi IV LP
Medicxi Co-Invest IV LP
10% Owner		 0 $0 7,464,572
(Indirect)		 View
2024-01-18
Option Award		 2024-01-22
8:22 pm		 N/A
2034-01-17		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 120,000 $0 220,609
(Direct)		 View
2024-01-18
Option Award		 2024-01-22
8:21 pm		 N/A
2034-01-17		 Phathom Pharmaceuticals Inc. PHAT Nabulsi Azmi
Chief Operating Officer		 130,000 $0 130,000
(Direct)		 View
2024-01-18
Option Award		 2024-01-22
8:19 pm		 N/A
2034-01-17		 Phathom Pharmaceuticals Inc. PHAT Curran Terrie
President and Chief Executive		 475,000 $0 475,000
(Direct)		 View
2023-11-01
Option Award		 2023-11-03
4:55 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 22,500 $0 106,322
(Direct)		 View
2023-11-01
Option Award		 2023-11-03
4:54 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Nabulsi Azmi
Chief Operating Officer		 32,500 $0 1,031,346
(Direct)		 View
2023-11-01
Option Award		 2023-11-03
4:53 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Curran Terrie
President and Chief Executive		 37,500 $0 430,751
(Direct)		 View
2023-07-14
Option Award(A)		 2023-07-21
8:30 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 25,000 $0 95,180
(Direct)		 View
2023-07-14
Option Award		 2023-07-17
5:00 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 25,000 $1 96,314
(Direct)		 View
2023-07-14
Option Award		 2023-07-17
5:00 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Curran Terrie
President and Chief Executive		 200,000 $0 393,251
(Direct)		 View
2023-07-14
Option Award		 2023-07-17
5:00 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Nabulsi Azmi
Chief Operating Officer		 110,000 $0 998,846
(Direct)		 View
2023-06-02
Option Award		 2023-06-05
6:37 pm		 N/A
N/A		 Phathom Pharmaceuticals Inc. PHAT Parikh Asit
Director		 15,000 $7.4 47,500
(Direct)		 View
2023-05-25
Option Award		 2023-05-30
7:03 pm		 N/A
2033-05-24		 Phathom Pharmaceuticals Inc. PHAT Topper James N
Director
10% Owner		 24,000 $0 5,867,924
(Direct)		 View
2023-05-25
Option Award		 2023-05-30
7:01 pm		 N/A
2033-05-24		 Phathom Pharmaceuticals Inc. PHAT Stenhouse Mark
Director		 24,000 $0 24,000
(Direct)		 View
2023-05-25
Option Award		 2023-05-30
6:57 pm		 N/A
2033-05-24		 Phathom Pharmaceuticals Inc. PHAT Socks David A
Director		 24,000 $0 1,235,756
(Direct)		 View
2023-05-25
Option Award		 2023-05-30
6:55 pm		 N/A
2033-05-24		 Phathom Pharmaceuticals Inc. PHAT Parikh Asit
Director		 24,000 $0 47,500
(Direct)		 View
2023-05-25
Option Award		 2023-05-30
6:53 pm		 N/A
2033-05-24		 Phathom Pharmaceuticals Inc. PHAT FIELDS HEIDI
Director		 24,000 $0 24,000
(Direct)		 View
2023-05-25
Option Award		 2023-05-30
6:48 pm		 N/A
2033-05-24		 Phathom Pharmaceuticals Inc. PHAT KARBE FRANK
Director		 24,000 $0 24,000
(Direct)		 View
2023-05-25
Option Award		 2023-05-30
6:46 pm		 N/A
2033-05-24		 Phathom Pharmaceuticals Inc. PHAT COLA MICHAEL F
Director		 24,000 $0 33,798
(Direct)		 View
2023-01-19
Option Award		 2023-01-20
7:39 pm		 N/A
2033-01-18		 Phathom Pharmaceuticals Inc. PHAT Curran Terrie
President and Chief Executive		 260,000 $0 341,543
(Direct)		 View
2023-01-19
Option Award		 2023-01-20
7:35 pm		 N/A
2033-01-18		 Phathom Pharmaceuticals Inc. PHAT Nabulsi Azmi
Chief Operating Officer		 120,000 $0 952,622
(Direct)		 View
2023-01-19
Option Award		 2023-01-20
7:32 pm		 N/A
2033-01-18		 Phathom Pharmaceuticals Inc. PHAT Henderson Molly
CFO and CBO		 88,000 $0 133,386
(Direct)		 View
(A) Indicate amendment filing.
Goto Prev, 0, 1, 2, 3, 4, Next